Abstract
Heat-labile enterotoxin (LT) is a protein toxin produced by enterotoxigenic Escherichia coli (ETEC). As a bacterial toxin, LT holotoxin can enter intestinal epithelial cells and cause diarrhea. In addition, LT is also a powerful mucosal adjuvant capable of enhancing the strong immune responses to co-administered antigens. However, the LT immunological mechanism is still not clear in some aspects, especially with the respect to how the LTA subunit functions alone. Here, we discovered that the A2 domain of LTA could carry a fluorescent protein into cells, whose function is similar to a cell-penetrating peptide. The transmembrane-transporting ability of the A2 domain is non-specific in its cell-penetrating function, which was shown through testing with different cell types. Moreover, the LTA2 fusion protein penetrated a fluorescently labeled cell membrane that identified LTA2 internalization through membrane transport pathways, and showed it finally localized in the endoplasmic reticulum. Furthermore, low-temperature stress and pharmacological agent treatments showed that the LTA2 internalization route is a temperature-dependent process involving the clathrin-mediated endocytosis and the macropinocytosis pathways. These results could explain the internalization of the LTA subunit alone without the LTB pentamer, contributing to a better understanding of LTA working as a mucosal adjuvant; they also suggest that the A2 domain could be used as a novel transport vehicle for research and treatment of disease.
Similar content being viewed by others
References
Beddoe T, Paton AW, Le Nours J, Rossjohn J, Paton JC (2010) Structure, biological functions and applications of the AB5 toxins. Trends Biochem Sci 35:411–418. doi:10.1016/j.tibs.2010.02.003
Carver LA, Schnitzer JE (2003) Caveolae: mining little caves for new cancer targets. Nat Rev Cancer 3:571–581. doi:10.1038/nrc1146
Chang CC, Wu M, Yuan F (2014) Role of specific endocytic pathways in electrotransfection of cells. Mol Ther Methods Clin Dev 1:14058. doi:10.1038/mtm.2014.58
Chao TY, Raines RT (2011) Mechanism of ribonuclease A endocytosis: analogies to cell-penetrating peptides. Biochemistry 50:8374–8382. doi:10.1021/bi2009079
Chen X, Zaro JL, Shen WC (2013) Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev 65:1357–1369. doi:10.1016/j.addr.2012.09.039
Chu JJ, Ng ML (2004) Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J Virol 78:10543–10555. doi:10.1128/JVI.78.19.10543-10555.2004
da Hora VP, Conceicao FR, Dellagostin OA, Doolan DL (2011) Non-toxic derivatives of LT as potent adjuvants. Vaccine 29:1538–1544. doi:10.1016/j.vaccine.2010.11.091
de Haan L, Feil IK, Verweij WR, Holtrop M, Hol WG, Agsteribbe E, Wilschut J (1998) Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin. Eur J Immunol 28:1243–1250. doi:10.1002/(SICI)1521-4141(199804)28:04<1243::AID-IMMU1243>3.0.CO;2-E
De Haan L, Holtrop M, Verweij WR, Agsteribbe E, Wilschut J (1999) Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin. Immunology 97:706–713
Dutta D, Donaldson JG (2012) Search for inhibitors of endocytosis: intended specificity and 0unintended consequences. Cell Logist 2:203–208. doi:10.4161/cl.23967
Eiriksdottir E, Konate K, Langel U, Divita G, Deshayes S (2010) Secondary structure of cell-penetrating peptides controls membrane interaction and insertion. Biochim Biophys Acta 1798:1119–1128. doi:10.1016/j.bbamem.2010.03.005
Elouahabi A, Ruysschaert JM (2005) Formation and intracellular trafficking of lipoplexes and polyplexes. Mol Ther 11:336–347. doi:10.1016/j.ymthe.2004.12.006
Fessler MB, Parks JS (2011) Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J Immunol 187:1529–1535. doi:10.4049/jimmunol.1100253
Fiser A, Sali A (2003) Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol 374:461–491. doi:10.1016/s0076-6879(03)74020-8
Green MR, Sambrook J (2012) Molecular cloning: a laboratory manual vol 1. Cold Spring Harbor Laboratory Press, New York
Koivusalo M, Welch C, Hayashi H, Scott CC, Kim M, Alexander T, Touret N, Hahn KM, Grinstein S (2010) Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol 188:547–563. doi:10.1083/jcb.200908086
Kruger NJ (2009) The Bradford method for protein quantitation. In: Walker JM (ed) The protein protocols handbook. Springer, pp 17–24
Leach S, Clements JD, Kaim J, Lundgren A (2012) The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens. PLoS One 7:e51718. doi:10.1371/journal.pone.0051718
Lin N, Zheng W, Li L, Liu H, Wang T, Wang P, Ma X (2014) A novel system enhancing the endosomal escapes of peptides promotes Bak BH3 peptide inducing apoptosis in lung cancer A549 cells. Target Oncol 9:163–170. doi:10.1007/s11523-013-0282-9
Ma X, Yao B, Zheng W, Li L (2010) Comparative study on characterization of recombinant B subunit of E. coli heat-labile enterotoxin (rLTB) prepared from E. coli and P. patoris. J Microbiol Biotechnol 20:550–557
Mae M, Langel U (2006) Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr Opin Pharmacol 6:509–514. doi:10.1016/j.coph.2006.04.004
Mano M, Teodosio C, Paiva A, Simoes S, Pedroso de Lima MC (2005) On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide. Biochem J 390:603–612. doi:10.1042/BJ20050577
Margus H, Padari K, Pooga M (2012) Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. Mol Ther 20:525–533. doi:10.1038/mt.2011.284
McCluskey A, Daniel JA, Hadzic G, Chau N, Clayton EL, Mariana A, Whiting A, Gorgani NN, Lloyd J, Quan A, Moshkanbaryans L, Krishnan S, Perera S, Chircop M, von Kleist L, McGeachie AB, Howes MT, Parton RG, Campbell M, Sakoff JA, Wang X, Sun JY, Robertson MJ, Deane FM, Nguyen TH, Meunier FA, Cousin MA, Robinson PJ (2013) Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis. Traffic 14:1272–1289. doi:10.1111/tra.12119
Merritt EA, Pronk SE, Sixma TK, Kalk KH, van Zanten BA, Hol WG (1994) Structure of partially-activated E. coli heat-labile enterotoxin (LT) at 2.6A resolution. FEBS Lett 337:88–92
Mohamed NA, Mohamed R, Chong TT (2012) Homology modeling of coagulase in Staphylococcus aureus. Bioinformation 8:412–414. doi:10.6026/97320630008412
Norton EB, Branco LM, Clements JD (2015) Evaluating the A-subunit of the heat-labile toxin (LT) as an immunogen and a protective antigen against enterotoxigenic Escherichia coli (ETEC). PLoS One 10:e0136302. doi:10.1371/journal.pone.0136302
Norton EB, Lawson LB, Freytag LC, Clements JD (2011) Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant. Clin Vaccine Immunol 18:546–551. doi:10.1128/CVI.00538-10
Norton EB, Lawson LB, Mahdi Z, Freytag LC, Clements JD (2012) The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens. Infect Immun 80:2426–2435. doi:10.1128/IAI.00181-12
Rappuoli R, Pizza M, Douce G, Dougan G (1999) Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol Today 20:493–500
Sixma TK, Pronk SE, Kalk KH, Wartna ES, van Zanten BA, Witholt B, Hol WG (1991) Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351:371–377. doi:10.1038/351371a0
Sjokvist Ottsjo L, Flach CF, Clements J, Holmgren J, Raghavan S (2013) A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection. Infect Immun 81:1532–1540. doi:10.1128/IAI.01407-12
Spangler BD (1992) Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev 56:622–647
Trabulo S, Cardoso AL, Mano M, de Lima MCP (2010) Cell-penetrating peptides—mechanisms of cellular uptake and generation of delivery systems. Pharmaceuticals 3:961–993. doi:10.3390/ph3040961
Trehin R, Merkle HP (2004) Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm 58:209–223. doi:10.1016/j.ejpb.2004.02.018
Wang J, Wang Y, Liang W (2012) Delivery of drugs to cell membranes by encapsulation in PEG-PE micelles. J Control Release 160:637–651. doi:10.1016/j.jconrel.2012.02.021
Xia T, Rome L, Nel A (2008) Nanobiology: particles slip cell security. Nat Mater 7:519–520. doi:10.1038/nmat2213
Yamamoto T, Tamura T, Yokota T (1984) Primary structure of heat-labile enterotoxin produced by Escherichia coli pathogenic for humans. J Biol Chem 259:5037–5044
Yang ST, Zaitseva E, Chernomordik LV, Melikov K (2010) Cell-penetrating peptide induces leaky fusion of liposomes containing late endosome-specific anionic lipid. Biophys J 99:2525–2533. doi:10.1016/j.bpj.2010.08.029
Acknowledgments
This research was supported by the National Natural Science Foundation (30873190, 31300660), Science and Technology Innovation Action Plan of Shanghai (14431904300), Shanghai Pujiang Program (13PJD012), and a Foundation for Young Teacher from Education Ministry of China (20120074120027) and partially supported by Open Funding Project of the State Key Laboratory of Bioreactor Engineering.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Electronic Supplementary Material
ESM 1
(PDF 266 kb)
Rights and permissions
About this article
Cite this article
Liu, D., Guo, H., Zheng, W. et al. Discovery of the cell-penetrating function of A2 domain derived from LTA subunit of Escherichia coli heat-labile enterotoxin. Appl Microbiol Biotechnol 100, 5079–5088 (2016). https://doi.org/10.1007/s00253-016-7423-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-016-7423-x